MYocardial DOmmages Related to COVID-19
- Conditions
- MyocarditisCovid19Non Ischemic Myocardial InjuryMyocardial InfarctionTroponin Elevation
- Interventions
- Biological: Biological dataOther: Clinical data
- Registration Number
- NCT04498065
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Brief Summary
Myocardial injury, as assessed by elevation of cardiac troponins (Tnc), is frequent among patients with COVID-19. Although rare autopsy cases reported COVID-19 related myocardial inflammation, the origin of Tnc elevation is unknown to date. Several cardiac causes, such as myocarditis, non-ischemic myocardial injury (NIMI), or myocardial infarction (MI) may lead to Tnc kinetic. Our work will test the hypothesis that during SARS-Cov2 infection, the elevation of cardiac biomarkers could be linked to the occurrence of myocarditis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 273
- COVID-19 positive patient hospitalized < 72 h after symptoms onset with troponin assessement.
- patients hospitalized > 72h after symptom onset
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description B Biological data COVID positive and Troponin negative A Clinical data COVID positive and Troponin positive A Biological data COVID positive and Troponin positive B Clinical data COVID positive and Troponin negative
- Primary Outcome Measures
Name Time Method characterize the myocardial damage associated with CoV-2 SARS infection Through study completion, an average of 2 years Myocardtitis diagnosis in patients COVID+ and troponin+
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Chu Dijon Bourgogne
🇫🇷Dijon, France